Procurement Summary
Country: USA
Summary: Maxcyte Expert Gtx Electroporation Device and Installationoperational Qualification Iqoq
Deadline: 07 Aug 2026
Posting Date: 30 Jul 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 146201100
Document Ref. No.: 26-008363
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
MaxCyte ExPERT GTx Electroporation Device and Installation/Operational Qualification (IQ/OQ)
Product Service Code (PSC): 6640 - Laboratory Equipment and Supplies
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Size Standard: 1, 000 Employees
Place of Performance:
National Institutes of Health
Clinical Center
Bethesda, MD 20892
POTS: 26-008363
Description
This notice is issued for informational purposes only and does not constitute a request for quotations. A solicitation will not be issued and quotations will not be requested.
The following items are required for this procurement:
Units/Part Number/Description
1/E-GTX-A/Expert GTx Flow Electroporation Platform for cGMP and Clinical Applications, Generation 3 with accessories
1/IQOQ/IQOQ Services and Installation
1/Estimated Freight
The National Institutes of Health (NIH), Clinical Center, Office of Purchasing and Contracts, on behalf of the Center for Cellular Engineering, intends to award a firm-fixed-price contract on a sole source basis to MaxCyte, Inc., Rockville, MD 20850, for the purchase of a MaxCyte ExPERT GTx Electroporation Device and associated Installation Qualification/Operational Qualification (IQ/OQ) services.
Background
The Center for Cellular Engineering (CCE) manufactures cell-based therapies for patients who have either exhausted all standard treatment options or have no available standard therapies.
CCE manufacturing operations are regulated under Current Good Manufacturing Practices (cGMP) as mandated by the U.S. Food and Drug Administration (FDA) under:
21 CFR Part 210
21 CFR Part 211
21 CFR Part 600
21 CFR Part 1271
The electroporation device is used to introduce genetic material (DNA, RNA) and proteins into cells during the development and manufacturing of cell-based therapies.
The current electroporation system in use at CCE is the MaxCyte Gen2 GT model, which will no longer b...
Notice ID: 26-008363
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Office: national institutes of health olao
Product Service Code: 6640 - laboratory equipment and supplies
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Inactive Dates: aug 08, 2026
Inactive Policy: manual
Documents
Tender Notice